SHARMEH Stock Screener | Share Price & Fundamental Analysis

SHARMEH Healthcare Service Provider
Screen SHARMEH share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹130.05
▼ -1.35 (-1.03%)
2026-01-06 00:00:00
Market Cap ₹41.71 Cr.
P/B Ratio 3.56
EPS (TTM) ₹3.79
Dividend Yield -
Debt to Equity 0.31
52W High ₹233.90
52W Low ₹62.64
Operating Margin 11.00%
Profit Margin 3.03%
Revenue (TTM) ₹33.00
EBITDA ₹4.00
Net Income ₹1.00
Total Assets ₹28.00
Total Equity ₹13.00

SHARMEH Share Price History - Stock Screener Chart

Screen SHARMEH historical share price movements with interactive charts. Analyze price trends and patterns.

SHARMEH Company Profile - Fundamental Screener

Screen SHARMEH company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SHARMEH shares.
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
ISIN INE465H01012

SHARMEH Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen SHARMEH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 28 25 24 19 19 20 22 16 18 15
Current Assets 15 7 12 10 11 12 15 8 9 9
Fixed Assets 9 8 9 7 6 4 5 6 6 6
Liabilities
Total Liabilities 28 25 24 19 19 20 22 16 18 15
Current Liabilities 1 1 2 2 2 2 1 2 2 2
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 13 11 11 10 9 8 8 8 8 6
Share Capital 4 4 4 4 4 4 4 4 4 4
Reserves & Surplus 8 7 6 5 5 4 4 4 3 2
Screen SHARMEH income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 33 30 24 21 17 11 16 16 16 17 17 17
Expenses 30 26 20 17 15 9 14 14 15 16 16 15
EBITDA 4 4 3 3 2 2 2 2 2 2 1 2
Operating Profit % 11.00% 12.00% -10.00% 16.00% 13.00% -8.00% 12.00% 4.00% 9.00% 10.00% 5.00% 8.00%
Depreciation 2 2 2 1 1 1 0 1 1 1 1 1
Interest 1 1 1 1 1 1 1 1 1 1 1 1
Profit Before Tax 2 1 1 1 1 1 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 1 1 1 1 1 0 0 0 0 0 1
EPS 3.90 3.79 2.02 2.96 2.07 1.94 1.18 0.81 0.40 0.26 0.09 1.74

SHARMEH Cash Flow Screener - Liquidity Fundamentals

Screen SHARMEH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 7 -1 1 2 1 1 -1 3 1 0
Investing Activities -3 5 -4 -2 3 -2 2 0 -1 0
Financing Activities -4 -4 3 -2 -2 -5 5 -3 0 0
Net Cash Flow 0 0 0 -2 2 -5 5 0 0 0
Screen SHARMEH shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar
Promoter Holding 53.63% 53.63% 53.63% 53.63% 53.63% 53.63% 53.63% 53.63%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 33.50% 33.50% 33.49% 32.83% 32.83% 32.92% 33.49% 33.50%
Other Holding 12.86% 12.86% 12.88% 13.53% 13.53% 13.44% 12.87% 12.86%
Shareholder Count 4,068 4,147 4,377 3,698 3,697 3,778 3,967 3,698

SHARMEH Dividend Screener - Share Yield Analysis

Screen SHARMEH dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
No dividends declared by SHARMEH.

SHARMEH Index Membership - Market Screener Classification

Screen SHARMEH by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
SHARMEH is not part of any tracked indices.
Only major market indices are tracked in our system.

SHARMEH Market Events Screener - Corporate Actions

Screen SHARMEH market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -19.83%
Annual General Meeting NA -16.46%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -3.69%
2025-08-08 2025-08-08 Quarterly Result Announcement NA -4.46%
2025-05-23 2025-05-23 Quarterly Result Announcement NA -1.35%
2025-01-10 2025-01-10 Quarterly Result Announcement NA 10.38%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -5.86%

SHARMEH Competitors Screener - Peer Comparison

Screen SHARMEH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 24,700 46.83 2,555 11.28% 492 51.43
Vijaya Diagnostic Centre 10,881 70.34 700 23.06% 144 61.34
Metropolis Healthcare 10,019 61.96 1,346 10.64% 146 53.04
Thyrocare Technologies 7,309 56.28 702 20.80% 91 53.15
Nephrocare Health Services 4,760 68.04 770 33.97% 67
Krsnaa Diagnostics 2,379 28.37 743 16.70% 78 46.09
Suraksha Diagnostic 1,441 45.66 256 15.11% 31 45.86
One Global Service Provider 1,237 28.65 148 134.60% 19 58.56
3B BlackBio DX 1,214 24.67 112 28.72% 48 56.43
Sastasundar Ventures 1,004 -103.51 1,171 -18.47% -134 60.55

SHARMEH Company Announcements - News Screener

Screen SHARMEH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-01-03 Closure of Trading Window View
2025-11-14 Intimation Of Reconstitution Of Audit Committee And Nomination And Remuneration Committee Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 View
2025-11-14 Announcement under Regulation 30 (LODR)-Resignation of Director View
2025-11-14 Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 View
2025-11-14 Board Meeting Outcome for Outcome Of Board Meeting Held On November 14 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. View
2025-11-04 Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 View
2025-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-10-01 Shareholder Meeting / Postal Ballot-Scrutinizers Report View
2025-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM View
2025-09-27 Closure of Trading Window View
2025-09-22 Letter To Shareholders As Per Requirements Of Regulation 36(1)(B) Of The SEBI (LODR) Regulation 2015 - Annual Report 2024-2025 And 36Th E-AGM Notice View
2025-09-08 Reg. 34 (1) Annual Report. View
2025-09-08 Notice Of 36Th Annual General Meeting Schedule To Be Held On 30Th September 2025. View
2025-09-06 Intimation Of 36Thannual General Meeting (AGM) Of The Company View
2025-09-06 Intimation Of 36Th Annual General Meeting (AGM) Of The Company Cut-Off Date For Voting And E-Voting View
2025-09-06 Notice Of Book Closure For The Purpose Of Annual General Meeting To Be Held On Tuesday The September 30 2025. View
2025-09-06 Announcement under Regulation 30 (LODR)-Change in Management View
2025-09-06 Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday September 06 2025. View
2025-08-08 Appointment Of Secretarial Auditor - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. View
2025-08-08 Approval Of Standalone Unaudited Financial Results For The Quarter Ended 30Th June 2025 Along With Limited Review Report. View